Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 4
1952 1
1953 1
1955 1
1956 1
1957 1
1958 1
1963 2
1968 1
1970 1
1971 1
1972 1
1973 1
1976 1
1980 1
1981 1
1982 1
1983 3
1985 3
1989 1
1990 1
1991 1
1993 2
1994 1
1995 2
1996 3
1997 2
1998 3
1999 2
2000 2
2001 3
2002 2
2003 4
2004 5
2005 10
2006 2
2007 8
2008 8
2009 7
2010 9
2011 11
2012 6
2013 2
2014 1
2015 2
2016 3
2017 4
2018 4
2019 1
2020 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 16080471

133 results
Results by year
Filters applied: . Clear all
Page 1
Serum levels of surfactant protein D predict the anti-tumor activity of gefitinib in patients with advanced non-small cell lung cancer.
Yamaguchi H, Soda H, Nakamura Y, Takasu M, Tomonaga N, Nakano H, Doi S, Nakatomi K, Nagashima S, Takatani H, Fukuda M, Hayashi T, Tsukamoto K, Kohno S. Yamaguchi H, et al. Cancer Chemother Pharmacol. 2011 Feb;67(2):331-8. doi: 10.1007/s00280-010-1325-x. Epub 2010 Apr 17. Cancer Chemother Pharmacol. 2011. PMID: 20401612 Clinical Trial.
133 results